DIAGNOSING DIGOXIN TOXICITY BY COMBINED MEASUREMENT OF PLASMA DIGOXIN CONCENTRATIONS AND ERYTHROCYTIC RB-86 UPTAKE

DIAGNOSING DIGOXIN TOXICITY BY COMBINED MEASUREMENT OF PLASMA DIGOXIN CONCENTRATIONS AND ERYTHROCYTIC RB-86 UPTAKE

Библиографические подробности
Главные авторы:	Aronson, J, Carver, J
Формат:	Journal article
Опубликовано:	1983

Схожие документы

Monitoring digoxin therapy. The use of plasma digoxin concentration measurements in the diagnosis of digoxin toxicity.
по: Aronson, J, и др.
Опубликовано: (1978)

Indications for the measurement of plasma digoxin concentrations.
по: Aronson, J
Опубликовано: (1983)

The acute changes seen in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: pharmacological and therapeutic implications for chronic digoxin therapy.
по: Ford, A, и др.
Опубликовано: (1979)

Interaction of digoxin with quinine.
по: Aronson, J, и др.
Опубликовано: (1981)

Digoxin revisited.
по: Aronson, J
Опубликовано: (1998)

ERYTHROCYTIC DIGOXIN RECEPTOR NUMBERS AND ACTIVITY - RELATION TO CLINICAL CHANGES FOLLOWING DIGOXIN WITHDRAWAL AFTER LONG-TERM TREATMENT FOR HEART-FAILURE IN SINUS RHYTHM
по: Pugh, S, и др.
Опубликовано: (1982)

The characteristics of the binding of 12-alpha-[3H]-digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapy.
по: Ford, A, и др.
Опубликовано: (1979)

Changes in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients receiving digoxin during the early phases of treatment of cardiac failure in regular rhythm and of atrial fibrillation.
по: Ford, A, и др.
Опубликовано: (1979)

The use of colour vision measurement in the diagnosis of digoxin toxicity.
по: Aronson, J, и др.
Опубликовано: (1980)

Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity
по: Sophia Sheikh, и др.
Опубликовано: (2024-06-01)

Clinical pharmacokinetics of digoxin 1980.
по: Aronson, J
Опубликовано: (1980)

MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION
по: S. F. Zadvorev, и др.
Опубликовано: (2018-05-01)

ABC of monitoring drug therapy. Digoxin.
по: Aronson, J, и др.
Опубликовано: (1992)

Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response.
по: Aronson, J, и др.
Опубликовано: (1977)

Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment
по: Antonella Colella, и др.
Опубликовано: (2022-06-01)

Ten Years of Experience in Treating Patients With Digoxin Toxicity Without Using Digoxin Fab Antibody
по: Farzad Gheshlagh, и др.
Опубликовано: (2021-01-01)

Monitoring digoxin therapy: III. How useful are the nomograms?
по: Aronson, J
Опубликовано: (1978)

Digoxin-like factor in infants of diabetic mothers not receiving digoxin therapy
по: M Yurdakök, и др.
Опубликовано: (1989-10-01)

Efficiency of individual dosage of digoxin with calculated concentration
по: Zhao L, и др.
Опубликовано: (2014-07-01)

A study of the transport of lithium across the erythrocyte membrane in vivo and of the effects of the ion transport inhibitors digoxin and dipyridamole.
по: Wood, A, и др.
Опубликовано: (1989)

Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution.
по: Aronson, J, и др.
Опубликовано: (1977)

Effects of Age, Gender, and Comorbid Diseases on Serum Digoxin Levels During Digoxin Treatment
по: Zeynep ÖZTÜRK, и др.
Опубликовано: (2018-01-01)

Appropriateness of digoxin level monitoring
по: MR Mordasini, и др.
Опубликовано: (2002-09-01)

Neglected facts in digoxin intoxication
по: Sibel Ocak Serin
Опубликовано: (2017-06-01)

THE EFFECT OF DIGOXIN ON THE INVIVO DISPOSITION OF AN ORAL LOAD OF RUBIDIUM CHLORIDE
по: Aronson, J, и др.
Опубликовано: (1982)

Treatment with Digoxin – is it a clinical challenge? A Retrospective Analysis of Hospitalizations due to Digoxin intoxication
по: Marcin Wais, и др.
Опубликовано: (2024-04-01)

Severe digoxin intoxication: A case report of the use of digoxin-specific Fab antibody fragments
по: Tadej Petreski, и др.
Опубликовано: (2023-08-01)

Clinical signs and symptoms of toxic serum digoxin levels in neonates
по: Mehmet Mutlu, и др.
Опубликовано: (2019-04-01)

Study the toxicity of digoxin on liver and their transaminase enzymes level in rat
по: Abbas Khadhair, и др.
Опубликовано: (2017-12-01)

Digoxin for Atrial Fibrillation in Spinal Anesthesia
по: Maryam Vosoughian, и др.
Опубликовано: (2024-03-01)

Preparation of Nanoparticles of Digoxin Solid Lipid
по: Ping Luo, и др.
Опубликовано: (2017-12-01)

Inadvertent Intrathecal Administration of Digoxin, with Review of the Literature
по: Burton J. Tabaac, и др.
Опубликовано: (2023-01-01)

Unmasking the Role of Uptake Transporters for Digoxin Uptake Across the Barriers of the Central Nervous System in Rat
по: Kunal S Taskar, и др.
Опубликовано: (2017-03-01)

In vivo cation transport during short-term and long-term digoxin therapy.
по: Boon, N, и др.
Опубликовано: (1986)

The effect of cholestyramıne on dogs with acute digoxin toxicosis
по: Abdullah Başoğlu, и др.

Digoxin and Heart Failure: Are We Clear Yet?
по: Amit Gupta, и др.
Опубликовано: (2017-04-01)

An HPLC method for the determination of digoxin in dissolution samples
по: Milenković Miroslav Ž., и др.
Опубликовано: (2010-01-01)

EFFICACY OF DIGOXIN IN THE MANAGEMENT OF IDIOPATHIC CARDIOMYOPATHY IN DOGS
по: R. Vijayan, и др.
Опубликовано: (2003-01-01)

A DNA-Based Assay for Digoxin Detection
по: Michael V. Kjelstrup, и др.
Опубликовано: (2018-03-01)

EFFICACY OF DIGOXIN IN THE MANAGEMENT OF IDIOPATHIC CARDIOMYOPATHY IN DOGS
по: R. Vijayan, и др.
Опубликовано: (2014-01-01)